ArticleCell death & disease2024

Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis.

Yunshang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.